Royalty Pharma Plc Cl A (RPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RPRX | AMGN | GILD | CELG | BIIB |
| Company | Royalty Pharma Plc Cl A | Amgen Inc | Gilead Sciences Inc | Celgene Corp | Biogen Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 28.50 | 301.75 | 65.43 | 108.01 | 221.52 |
| High | 28.58 | 302.91 | 66.14 | 108.59 | 221.98 |
| Low | 28.22 | 299.50 | 65.16 | 107.27 | 216.08 |
| Last | 28.24 | 299.56 | 65.86 | 108.24 | 217.43 |
| Change | -0.25 | +0.08 | +0.32 | +0.11 | -3.99 |
| % Change | -0.88% | +0.03% | +0.49% | +0.10% | -1.80% |
| Volume | 943,275 | 982,447 | 1,717,392 | 191,230,496 | 425,213 |
| 20-Day Average Volume | 2,713,057 | 2,747,910 | 7,320,349 | 16,188,930 | 1,339,498 |
| Previous Close | 28.49 | 299.48 | 65.54 | 108.13 | 221.42 |
| Industry | Finance - Misc Services | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | No | Yes |
| Technicals | |||||
| 20-Day Moving Average | 28.18 | 275.27 | 66.48 | 108.17 | 204.44 |
| 20-Day Raw Stochastic | 41.82% | 63.77% | 27.26% | 63.25% | 83.42% |
| 20-Day Relative Strength | 45.69% | 62.98% | 36.28% | 64.69% | 54.88% |
| Weighted Alpha | -14.71 | +28.04 | -19.55 | +46.30 | -28.10 |
| Today's Opinion | 24% Sell | 40% Buy | 100% Sell | 100% Buy | 56% Sell |
| Previous Opinion | 8% Sell | 24% Buy | 100% Sell | 100% Buy | 56% Sell |
| Last Month's Opinion | 40% Buy | 24% Sell | 100% Sell | 100% Buy | 100% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.00% since 04/30/24 | +9.57% since 04/30/24 | +0.94% since 04/30/24 | -1.97% since 11/13/19 | +0.98% since 04/30/24 |
| Low | 27.70 on 05/01/24 | 273.38 on 05/01/24 | 64.33 on 05/03/24 | 107.27 on 11/20/19 | 213.11 on 05/03/24 |
| High | 28.99 on 05/02/24 | 322.60 on 05/03/24 | 66.14 on 05/07/24 | 110.53 on 11/14/19 | 222.40 on 05/06/24 |
| 1-Month | |||||
| %Chg | -3.20% since 04/05/24 | +11.19% since 04/05/24 | -5.42% since 04/05/24 | +5.14% since 10/18/19 | +6.41% since 04/05/24 |
| Low | 27.21 on 04/23/24 | 260.68 on 04/19/24 | 64.33 on 05/03/24 | 102.40 on 10/21/19 | 189.44 on 04/19/24 |
| High | 29.73 on 04/09/24 | 322.60 on 05/03/24 | 69.95 on 04/09/24 | 110.70 on 11/13/19 | 222.40 on 05/06/24 |
| 3-Month | |||||
| %Chg | -3.67% since 02/07/24 | +1.45% since 02/07/24 | -11.57% since 02/07/24 | +13.63% since 08/20/19 | -9.81% since 02/07/24 |
| Low | 27.21 on 04/23/24 | 260.68 on 04/19/24 | 64.33 on 05/03/24 | 93.41 on 08/23/19 | 189.44 on 04/19/24 |
| High | 31.66 on 02/27/24 | 322.60 on 05/03/24 | 76.21 on 03/11/24 | 110.70 on 11/13/19 | 244.95 on 02/12/24 |
| 6-Month | |||||
| %Chg | +2.56% since 11/07/23 | +10.72% since 11/07/23 | -18.36% since 11/07/23 | +14.14% since 05/20/19 | -11.68% since 11/07/23 |
| Low | 26.07 on 11/16/23 | 260.52 on 11/21/23 | 64.33 on 05/03/24 | 89.08 on 07/23/19 | 189.44 on 04/19/24 |
| High | 31.66 on 02/27/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 110.70 on 11/13/19 | 268.30 on 01/03/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 17,020,922 | 160,633,888 | 81,602,352 | 77,035,920 | 32,238,088 |
| Shares Outstanding, K | 597,435 | 536,376 | 1,245,077 | 711,714 | 145,597 |
| Annual Sales | 2,354,550,000 | 28,190,000,000 | 27,116,000,000 | 15,281,000,000 | 9,835,600,000 |
| Annual Net Income | 1,134,830,000 | 6,717,000,000 | 5,665,000,000 | 4,046,000,000 | 1,161,100,000 |
| Last Quarter Sales | 596,070,000 | 7,447,000,000 | 6,686,000,000 | 4,520,000,000 | 2,290,500,000 |
| Last Quarter Net Income | 494,340,000 | -113,000,000 | -4,170,000,000 | 1,691,000,000 | 393,400,000 |
| 60-Month Beta | 0.47 | 0.60 | 0.22 | 1.41 | -0.01 |
| Per-Share Information | |||||
| Most Recent Earnings | 1.15 on 02/15/24 | 3.96 on 05/02/24 | -1.32 on 04/25/24 | 2.99 on 10/31/19 | 3.67 on 04/24/24 |
| Latest Earnings Date | 05/09/24 | 05/02/24 | 04/25/24 | 10/31/19 | 04/24/24 |
| Most Recent Dividend | 0.210 on 02/15/24 | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | 05/16/24 | 05/16/24 | 06/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 6.47 | 16.71 | 16.07 | 10.99 | 14.50 |